World
Drugmakers Pledge to Avoid Safety Shortcuts on Covid Vaccine
- Companies will wait for key data to seek marketing approval
- Merck, Pfizer, Glaxo say patient safety is “top priority”
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Drugmakers racing to produce Covid-19 vaccines pledged to avoid shortcuts on science as they face pressure to rush a shot to market.